Point72 Hong Kong’s Vertex Pharmaceuticals VRTX Stock Holding History

Point72 Hong Kong’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-10,400	Closed	-$3.01M	–	1649
2022 Q3	$3.01M	Buy	10,400 +5,700	+121%	+$1.64M	0.11%	236
2022 Q2	$1.32M	Buy	+4,700	New	+$1.26M	0.05%	452
2022 Q1	–	Sell	-3,100	Closed	-$681K	–	2360
2021 Q4	$681K	Sell	3,100 -9,900	-76%	-$1.93M	0.02%	694
2021 Q3	$2.36M	Sell	13,000 -9,000	-41%	-$1.76M	0.08%	385
2021 Q2	$4.44M	Buy	+22,000	New	+$4.6M	0.14%	153
2021 Q1	–	Sell	-6,400	Closed	-$1.51M	–	2245
2020 Q4	$1.51M	Buy	+6,400	New	+$1.47M	0.07%	353

Other funds holding VRTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Point72 Hong Kong's VRTX Position: Q4 2022 in Review

Point72 Hong Kong sold out of Vertex Pharmaceuticals (VRTX) in Q4 2022, closing a stake of 16,683 shares — an estimated $4.83M sold.

Point72 Hong Kong first reported a position in VRTX in Q4 2014 and held it in 17 quarters. The position peaked at $4.83M in Q3 2022. 1,223 funds tracked by Wall St. Rank hold VRTX as of Q4 2022.

Point72 Hong Kong reported no remaining Vertex Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Point72 Hong Kong sold 16,683 Vertex Pharmaceuticals shares in Q4 2022, an estimated $4.83M.
Point72 Hong Kong first reported a position in Vertex Pharmaceuticals in Q4 2014 and held it in 17 quarters.
Point72 Hong Kong's Vertex Pharmaceuticals position peaked at $4.83M in Q3 2022.
1,223 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.